Skip to main content

DAN 5619 5 Pill - yellow round, 8mm

Pill with imprint DAN 5619 5 is Yellow, Round and has been identified as Diazepam 5 mg. It is supplied by Watson Laboratories, Inc.

Diazepam is used in the treatment of Anxiety; Back Pain; Endoscopy or Radiology Premedication; Alcohol Withdrawal; Status Epilepticus and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Diazepam 5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for DAN 5619 5

Diazepam 5 mg DAN 5619 5
Diazepam 5 mg DAN 5619 5
Diazepam 5 mg DAN 5619 5 Front
Diazepam 5 mg DAN 5619 5 Back
Diazepam 5 mg DAN 5619 5

Diazepam

Imprint
DAN 5619 5
Strength
5 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Benzodiazepine anticonvulsants, Benzodiazepines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose anhydrous, magnesium stearate, microcrystalline cellulose, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-5619 (Discontinued) Watson Pharmaceuticals, Inc.
00904-5880 (Discontinued) Major Pharmaceuticals
51862-0063 (Discontinued) Libertas Pharma
63739-0073 (Discontinued) McKesson Packaging Services
33261-0034 (Discontinued) Aidarex Pharmacuticals, LLC (repackager)
43063-0018 (Discontinued) PDRX Pharmaceuticals Inc. (repackager)
49999-0018 (Discontinued) Lake Erie Medical and Surgical Supply (repackager)
54569-4764 (Discontinued) A-S Medication Solutions, LLC (repackager)
54868-0059 (Discontinued) Physicians Total Care Inc. (repackager)
66267-0069 Nucare Pharmaceuticals Inc. (repackager)
66267-0776 Nucare Pharmaceuticals Inc. (repackager)
67544-0019 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.